The company’s revenues increased 19 percent, ahead of Zacks Consensus estimate. Zacks maintains a neutral rating for AmSurg stock.
At the end of December 2012, the company operated 250 ASCs. Of AmSurg’s centers, 149 perform GI procedures, 48 are multispecialty centers, 36 perform ophthalmology procedures and seven perform orthopedic procedures.
More Articles on Transactions and Valuation Issues:
13 Ambulatory Surgery Center Openings, Plans & Expansions
9 Statistics on Surgery Center Liquidity Based on Case Volume
ASC Sector M&A Activity: Outlook for 2014
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
